BDBM590788 1-(2-morpholinoethyl)-2-oxo-6-(pyrimidin-4-yl)-N- (spiro[3.3]heptan-2-yl)-1,2-dihydro-1,8-naphthyridine- 3-carboxamide::US11564928, Compound 35

SMILES O=C(NC1CC2(CCC2)C1)c1cc2cc(cnc2n(CCN2CCOCC2)c1=O)-c1ccncn1

InChI Key InChIKey=YEKQYKINYXBRAA-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 590788   

TargetCannabinoid receptor 2(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590788(US11564928, Compound 35 | 1-(2-morpholinoethyl)-2-...)
Affinity DataIC50: 7.5nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent

TargetCannabinoid receptor 1(Human)
Teon Therapeutics

US Patent
LigandPNGBDBM590788(US11564928, Compound 35 | 1-(2-morpholinoethyl)-2-...)
Affinity DataIC50: 358nMAssay Description:CB1R binding protocol involves the use of the same solution buffer used for both incubation and washing reaction (Tris-HCl, 50 mM; EDTA, 2.5 mM; MgCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2023
Entry Details
Go to US Patent